Metabolic illnesses change ACE2 articulation and increment COVID-19 seriousness Kumar Jeetendra | June 9, 2020 As the COVID-19 pandemic keeps on causing sickness and take lives over the world, plainly the infection influences distinctive populace fragments divergently. Another examination distributed on the preprint server medRxiv* in June 2020 reports that one instrument for this variable seriousness is the differential articulation of the ACE2 receptor in different metabolic conditions, along these …
Researchers distinguish aggravates that square replication of COVID-19 infection Kumar Jeetendra | July 12, 2020 Whilst the death toll from the COVID-19 pandemic mounts, the boffins worldwide carry on their push to create effective treatments and a vaccine to its highly infectious respiratory tract. The inhibitors demonstrate potent structural and chemical connections with an viral critical to this herpes virus’s capacity to proliferate. The very promising drug candidates – like …
Nitric oxide treatment can be essential in the battle against COVID-19 Kumar Jeetendra | July 27, 2020 Nitric oxide therapy could be critical in the world’s struggle against SARS-CoV-2, the coronavirus which causes COVID-19, according to a review by the George Washington University (GW). Nitric oxide is an antimicrobial and anti inflammatory molecule with key roles in pulmonary arterial role in the context of viral infections as well as other pulmonary diseases. …
FDA authorizes initial two COVID-19 serology tests Kumar Jeetendra | August 2, 2020 Today, the U.S. Food and Drug Administration approved the initial two COVID-19 serology tests which show an estimated amount of antibodies within somebody’s blood. Both tests from Siemens, the ADVIA Centaur COV2G and Attelica COV2G are what are known as”semi-quantitative” evaluations, meaning that they don’t show an exact measurement, but estimate the number of a …
Protein delivered by the human safe framework can emphatically hinder Sars-Cov-2 Kumar Jeetendra | August 3, 2020 A protein produced by the human immune system may strongly inhibit corona viruses, including Sars-Cov-2, the pathogen causing Covid-19. An international team from Germany, Switzerland and the USA successfully showed the LY6E-Protein prevents coronaviruses from causing the illness. “This finding may result in the development of new therapeutic approaches against coronaviruses,” says Professor Stephanie Pfänder …
UCI researchers develop novel molecule for COVID-19 treatment Kumar Jeetendra | August 6, 2020 When the coronavirus pandemic struck, nearly everyone in the University of California, Irvine — and colleges across the country — had to abandon campus. That’s because his laboratory, which designs and constructs chemical molecules, had the ideal equipment to aid in the international push to locate remedies for COVID-19. Nowick’s group set to work in …
Propelled investigation offers new experiences into safe framework’s job in serious COVID-19 Kumar Jeetendra | August 14, 2020 By conducting complex diagnoses of immune system stimulation in patients with acute COVID-19, researchers at Karolinska Institutet have managed to spot several cell types that play a key part in the immune reaction to the new coronavirus and the hyperinflammation found in severe cases of the disease. The results are published in the scientific journal …
Key China COVID-19 examination delivered results that affected ensuing exploration on Covid Kumar Jeetendra | September 18, 2020 Crucial China COVID-19 study produced results that Affected subsequent research on coronavirus Early in the start of the COVID-19 pandemic, a small study in China produced results that affected subsequent research on the virus. Researchers at the University of Cincinnati used the same research parameters on a much larger patient population and reached completely different …
‘Quiet’ influx of neurological results might be on its way due to COVID-19 Kumar Jeetendra | September 23, 2020 Is the world ready a tide of neurological consequences which might be on its way as a result of COVID-19? A group of neuroscientists and clinicians are examining the potential link between COVID-19 and increased risk of Parkinson’s disease, and measures to get ahead of the curve. In a review paper published today, researchers put …
Molecular investigation of COVID-19’s subsequent wave shows freak infections connected to quick spread Kumar Jeetendra | September 24, 2020 Molecular analysis of COVID-19’s powerful second wave in Houston — from May 12 to July 7 — shows that a mutated virus strain linked to higher transmission and infection rates than the coronavirus strains that caused Houston’s first wave. Gene sequencing results from 5,085 COVID-positive patients analyzed at Houston Methodist since early March show a …
New T-cell-based immunization procedure gives more extensive insurance against occasional flu Kumar Jeetendra | September 24, 2020 As Americans begin pulling their sleeves up for an annual flu vaccine, researchers at the University of Wisconsin-Madison have provided new insights into an alternate vaccine approach that provides wider protection against seasonal flu. In a study published in Cell Reports Medicine today (Sept. 22), scientists describe a T-cell-based vaccine strategy that’s effective against multiple …
PC model disentangles puzzle behind serious aggravation in individuals with COVID-19 Kumar Jeetendra | September 29, 2020 A study from the University of Pittsburgh School of Medicine and Cedars-Sinai addresses a mystery first raised in March: Why do some people with COVID-19 develop severe inflammation? The research shows how the molecular arrangement and arrangement of the SARS-CoV-2 spike protein–part of the virus that causes COVID-19–could be behind the inflammatory syndrome cropping up …
